NYSE - Delayed Quote • USD
Agilent Technologies, Inc. (A)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 6:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Apr 2024) | Next Qtr. (Jul 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 15 | 14 | 19 | 19 |
| Avg. Estimate | 1.19 | 1.45 | 5.5 | 6.1 |
| Low Estimate | 1.17 | 1.38 | 5.45 | 5.95 |
| High Estimate | 1.2 | 1.49 | 5.55 | 6.33 |
| Year Ago EPS | 1.27 | 1.43 | 5.44 | 5.5 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Apr 2024) | Next Qtr. (Jul 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 14 | 13 | 19 | 19 |
| Avg. Estimate | 1.58B | 1.72B | 6.77B | 7.22B |
| Low Estimate | 1.57B | 1.67B | 6.72B | 7.07B |
| High Estimate | 1.59B | 1.74B | 6.99B | 7.43B |
| Year Ago Sales | -- | -- | 6.83B | 6.77B |
| Sales Growth (year/est) | -- | -- | -0.90% | 6.60% |
Earnings History
| CURRENCY IN USD | 4/30/2023 | 7/31/2023 | 10/31/2023 | 1/31/2024 |
|---|---|---|---|---|
| EPS Est. | 1.26 | 1.36 | 1.34 | 1.22 |
| EPS Actual | 1.27 | 1.43 | 1.38 | 1.29 |
| Difference | 0.01 | 0.07 | 0.04 | 0.07 |
| Surprise % | 0.80% | 5.10% | 3.00% | 5.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Apr 2024) | Next Qtr. (Jul 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 1.19 | 1.45 | 5.5 | 6.1 |
| 7 Days Ago | 1.19 | 1.45 | 5.5 | 6.08 |
| 30 Days Ago | 1.19 | 1.45 | 5.5 | 6.08 |
| 60 Days Ago | 1.27 | 1.43 | 5.49 | 6.07 |
| 90 Days Ago | 1.26 | 1.43 | 5.47 | 6.05 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Apr 2024) | Next Qtr. (Jul 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 2 | 3 |
| Up Last 30 Days | 2 | 1 | 3 | 6 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | A | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -6.30% | -- | -- | 6.50% |
| Next Qtr. | 1.40% | -- | -- | 12.00% |
| Current Year | 1.10% | -- | -- | 5.30% |
| Next Year | 10.90% | -- | -- | 13.10% |
| Next 5 Years (per annum) | 8.05% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 16.19% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Barclays: Underweight to Underweight | 4/10/2024 |
| Upgrade | Stifel: Hold to Buy | 4/5/2024 |
| Maintains | Evercore ISI Group: In-Line to In-Line | 4/4/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 3/26/2024 |
| Maintains | Citigroup: Neutral to Neutral | 2/28/2024 |
| Maintains | UBS: Neutral to Neutral | 2/28/2024 |
Related Tickers
WAT Waters Corporation
311.30
+0.96%
TMO Thermo Fisher Scientific Inc.
573.60
+0.33%
MTD Mettler-Toledo International Inc.
1,238.09
+0.42%
DHR Danaher Corporation
246.58
+0.32%
IDXX IDEXX Laboratories, Inc.
499.30
+2.06%
QGEN Qiagen N.V.
41.65
+1.39%
IQV IQVIA Holdings Inc.
234.88
+0.38%
ILMN Illumina, Inc.
122.28
+1.02%
MEDP Medpace Holdings, Inc.
395.93
+1.58%
DGX Quest Diagnostics Incorporated
134.26
-0.86%